Tokyo Medical University Hospital
Department of Laboratory Medicine
and Molecular Genetics of Coagulation Disorders
Coagulation, Transfusion Medicine and Infectious Diseases

The Hemophilia Treatment Center (HTC) in Tokyo Medical University Hospital is providing a comprehensive care for hemophilia and other coagulation disorders, working with related departments. We are operating outpatient clinic from Mon. to Fri. (8:30-16:00) and Sat. except 2nd & 4th Sat.(8:30-11:00). We have an emergency care for 24hrs everyday.

Director:
Dr. Ei Kinai, Professor and Chairman

Physicians:
Dr. Kagehiro Amano
Dr. Takeshi Hagiwara
Dr. Mihoko Yotsumoto
Dr. Takashi Muramatsu
Dr. Ryoko Sekiya
Dr. Masato Bingo
Dr. Yushi Chikasawa
Dr. Akito Ichiki
Dr. Yoshiko Kamikubo
Dr. Ryui Miyashita
Dr. Tomoko Yamaguchi
Dr. Yuko Harada
Dr. Shun Kaneko

Nurse Coordinator:
Ms. Nozomi Tamura RN

Address: MAP
Tokyo Shinjuku Hemophilia Centre
Department of Laboratory Medicine
Tokyo Medical University Hospital
6-7-1 Nishi-shinnjuku, Shinjuku-Ku, Tokyo, Japan
160-0023

Phone: +81-3-3342-6111
Fax: +81-3-3340-5448
Email: fukutake@tokyo-med.ac.jp
Web site: http://labo-med.tokyo-med.ac.jp/

Available Coagulation factors
Factor VIII:
Recombinant; Advate (Baxter), KogenateFS (Bayer),
Plasma; Cross-eightM(Japan Red Cross)
Factor IX
Recombinant; Benefix(Pfizer)
Plasma; Novact M (Chemo-Thera), Christmasin M (Mitsubishi)
Inhibitor;
FEIBA (Baxter), NovoSeven (Novo Nordisk)
VWF;
Plasma; Confact F ( Chemo-Thera )
Factor XIII;
Plasma; Fibrogamin(CSL)